Literature DB >> 2965741

Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.

E Ciccone1, O Viale, C Bottino, D Pende, N Migone, G Casorati, G Tambussi, A Moretta, L Moretta.   

Abstract

These experiments were designed to define the ability of human TCR-gamma+ cells to recognize allogeneic cells. TCR-gamma+-enriched populations were obtained by treating peripheral blood E-rosetting cells with anti-CD4 and anti-CD8 mAbs. The resulting populations were CD2+4-8- expressed variable proportions of CD3+ cells (40-90%), and did not react with the WT31 mAb, which is specific for a framework determinant of the alpha/beta heterodimer that serves as receptor for antigen on most human T lymphocytes. After mixed lymphocyte culture with irradiated allogeneic cells for 7 d and 3 additional days in rIL-2 (100 U/ml), cells underwent proliferation in three of five individuals tested. In addition, MLC-derived cells lysed 51Cr-labeled PHA-induced blasts derived from the allogeneic cells used as stimulator, but not allogeneic unrelated or autologous blast cells. No cytotoxicity against autologous or allogeneic target cells could be induced by culturing CD3+4-8-WT31- lymphocytes in MLC with irradiated autologous cells. Surface iodination of allogeneic MLC-activated CD3+4-8-WT31- cells followed by lysis in 1% digitonin and immunoprecipitation with anti-CD3 mAb indicated that the CD3-associated molecules consisted of a major 45-kD band and a minor band of 43 kD. Northern blot analysis showed that mRNA for the gamma chain was expressed at high levels, whereas mRNAs for alpha and beta chains were missing. These data support the notion that TCR-gamma rather than TCR-alpha/beta is expressed in allospecific CD3-4-8-WT31- cell populations. Clones were further derived from MLC-stimulated CD3+4-8-WT31- populations. All the seven clones studied in detail maintained the surface phenotype as well as the cytolytic pattern of the original MLC populations, thus only specific allogeneic PHA-induced blasts were lysed. NK-sensitive as well as NK-resistant tumor targets were variably susceptible to lysis; therefore, specific cytolytic activity against allogeneic cells was not necessarily linked to the expression of MHC-nonrestricted cytotoxicity against tumor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965741      PMCID: PMC2188907          DOI: 10.1084/jem.167.4.1517

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes.

Authors:  J Borst; R J van de Griend; J W van Oostveen; S L Ang; C J Melief; J G Seidman; R L Bolhuis
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

2.  CD3+ WT31- peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer.

Authors:  A Poggi; C Bottino; M R Zocchi; G Pantaleo; E Ciccone; C Mingari; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

3.  Identification of a putative second T-cell receptor.

Authors:  M B Brenner; J McLean; D P Dialynas; J L Strominger; J A Smith; F L Owen; J G Seidman; S Ip; F Rosen; M S Krangel
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

4.  Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes.

Authors:  L A Matis; R Cron; J A Bluestone
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

5.  Cross-linking of human T cell receptor proteins: association between the T cell idiotype beta subunit and the T3 glycoprotein heavy subunit.

Authors:  M B Brenner; I S Trowbridge; J L Strominger
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

6.  Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.

Authors:  Y Yanagi; A Chan; B Chin; M Minden; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Human CD3+4-8-WT31- T lymphocyte populations expressing the putative T cell receptor gamma-gene product. A limiting dilution and clonal analysis.

Authors:  L Moretta; D Pende; C Bottino; N Migone; E Ciccone; S Ferrini; M C Mingari; A Moretta
Journal:  Eur J Immunol       Date:  1987-09       Impact factor: 5.532

8.  Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types.

Authors:  M P Lefranc; T H Rabbitts
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

9.  Characterization of CD3+, CD4-, CD8- clones expressing the putative T cell receptor gamma gene product. Analysis of the activation pathways leading to interleukin 2 production and triggering of the lytic machinery.

Authors:  S Ferrini; C Bottino; R Biassoni; A Poggi; R P Sekaly; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

10.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

Authors:  S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Maturation, selection and specificity of Tcr gamma delta T cells.

Authors:  L Lefrançois
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.

Authors:  B Balbi; D R Moller; M Kirby; K J Holroyd; R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 3.  The role of gamma delta T cells in the normal and disordered immune system.

Authors:  B Bröker; P M Lydyard; F Emmrich
Journal:  Klin Wochenschr       Date:  1990-05-17

4.  Human T cells expressing the gamma/delta T-cell receptor (TcR-1): C gamma 1- and C gamma 2-encoded forms of the receptor correlate with distinctive morphology, cytoskeletal organization, and growth characteristics.

Authors:  C E Grossi; E Ciccone; N Migone; C Bottino; D Zarcone; M C Mingari; S Ferrini; G Tambussi; O Viale; G Casorati
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.

Authors:  M Eto; Y Yoshikai; Y Nishimura; K Hiromatsu; T Maeda; K Nomoto; Y Y Kong; R T Kubo; J Kumazawa; K Nomoto
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

6.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Authors:  Michael A Poles; Shady Barsoum; Wenjie Yu; Jian Yu; Patricia Sun; Jeanine Daly; Tian He; Saurabh Mehandru; Andrew Talal; Martin Markowitz; Arlene Hurley; David Ho; Linqi Zhang
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS.

Authors:  D E Nilssen; F Müller; O Oktedalen; S S Frøland; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency.

Authors:  D E Nilssen; P Aukrust; S S Frøland; F Müller; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

10.  Association of increased numbers of peripheral blood double-negative T-lymphocytes with elevated serum IgG levels in severely handicapped children.

Authors:  Y Kawano; T Noma; I Yoshizawa; K Maruki; J Yata
Journal:  Eur J Pediatr       Date:  1994-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.